filmov
tv
Dr. Edith Perez on the Etirinotecan Pegol for HER2-Negative Breast Cancer
Показать описание
OncLive
cancer
oncology
Рекомендации по теме
0:01:20
Dr. Edith Perez on the Etirinotecan Pegol for HER2-Negative Breast Cancer
0:01:05
Meet Dr. Edith Perez | Minority Health Month | Stand Up To Cancer
0:01:25
Dr. Edith Perez on Immune Checkpoint Inhibition in Triple-Negative Breast Cancer
0:16:17
Dr. Edith Perez Discusses Anti-HER2 Therapies -- 2012 SABCS
0:15:51
Advances in Targeted Cancer Therapy with Dr. Edith Perez Bolt Biotherapeutics
0:09:06
PFF Summit 2019 | Keynote Speaker Dr. Edith Perez Q&A
0:04:15
Identifying Genes That Can Predict if Breast Cancer Drug Is Working - Mayo Clinic
0:05:37
Edith Perez, MD - Panelist (introduction)
0:10:20
What Does the Future of Cancer Research Look Like \\ Edith Perez
0:33:58
Translational Genomics: The Future is Now | Edith Perez, MD
0:04:26
ALTTO Trials Findings For Treating HER2+ Breast Cancer - Mayo Clinic
0:09:19
Conquering Cancer Personalized Medicine Is the Future \\ Edith Perez
0:02:58
We 'should' test next generation sequencing on metastatic breast cancer patients
0:21:39
IO better | Prof. Edith Perez
0:04:20
Immune Function Marker Does Not Predict Benefit of Trastuzumab in HER+ Breast Cancer Patients
0:02:18
Breast Cancer Study Finds New Type of Mutation - Mayo Clinic
0:03:00
Genes May Predict Trastuzumab Outcomes in Breast Cancer
0:06:55
Dr. Perez Accepts Her 2011 EVE Award - Mayo Clinic
0:45:18
CMC Considerations For In-Human Studies with Drs. Edith Perez And Nathan Ihle
0:06:37
The Estrogen-Receptor Antagonist Fulvestrant in Breast Cancer
0:10:57
The Race Against Breast Cancer: What Mayo Clinic Has Learned So Far
0:07:12
CLL Update Presented by Dr. Edith Perez
0:30:27
Breast Cancer Studies Presented by Dr. Edith A. Perez
0:12:42
Panel: Cancer Research, Prevention, & Education | Changing the Odds: The Hill's Cancer Summ...